• ___
  • Svenska
  • Contact
  • About IRLAB
    • About IRLAB
  • Therapeutic focus
    • Therapeutic focus
    • Parkinson’s disease
      • Patient portrait
    • PD-LIDs
    • PD-Falls
  • Project portfolio
    • Project portfolio
    • Mesdopetam (IRL790)
    • Pirepemat (IRL752)
    • IRL942 & 1009
    • Discovery phase
  • Research platform
    • ISP platform
    • Scientific publications
  • Newsroom
    • Newsroom
    • Presentations & events
    • Press releases
    • Event calendar
    • Image library
  • Investors
    • Investors
    • Financial reports
    • The share
      • Owners
      • Share capital development
      • PDMR transactions
      • Analysts
    • Financial calendar
    • Listing Nasdaq Stockholm Main Market 2020
    • Rights issue Feb 2020
    • Initial public offering 2017
  • Corporate Governance
    • Corporate Governance
    • General Meetings
      • Annual General Meeting 2021
      • Previous general meetings
    • Corporate governance reports
    • Board of directors
    • Nomination committee
      • Nomination Committee for AGM 2021
      • Previous nomination committees
    • Management
    • Auditor
    • Remuneration
    • Certified advisor
    • Internal control
    • Diversity
    • Articles of association
Hem>Corporate Governance>Corporate governance reports

Corporate governance reports

Share this:
  • Facebook
  • Twitter
  • Linkedin

Corporate governance report 2019

Published April 7, 2020.

In Swedish only.

Corporate governance report 2018

Published April 3, 2019.

In Swedish only.

Corporate governance report 2017

Published April 20, 2018.

In Swedish only.

  • Corporate Governance
    • Corporate Governance
    • General Meetings
      • Annual General Meeting 2021
      • Previous general meetings
    • Corporate governance reports
    • Board of directors
    • Nomination committee
      • Nomination Committee for AGM 2021
      • Previous nomination committees
    • Management
    • Auditor
    • Remuneration
    • Certified advisor
    • Internal control
    • Diversity
    • Articles of association

IRLAB Therapeutics AB (publ)

Arvid Wallgrens Backe 20

413 46 Göteborg

+46 31 757 38 00

Copyright © 2021 IRLAB

  • Integrity policy